These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38355986)

  • 81. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
    Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
    Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective.
    Zhu M; Li S; Kuang Y; Hill VB; Heimberger AB; Zhai L; Zhai S
    Front Oncol; 2022; 12():924245. PubMed ID: 35982952
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review.
    Jan Z; El Assadi F; Abd-Alrazaq A; Jithesh PV
    J Med Internet Res; 2023 Mar; 25():e44248. PubMed ID: 37000507
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Applying artificial intelligence for cancer immunotherapy.
    Xu Z; Wang X; Zeng S; Ren X; Yan Y; Gong Z
    Acta Pharm Sin B; 2021 Nov; 11(11):3393-3405. PubMed ID: 34900525
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Radiomics and "radi-…omics" in cancer immunotherapy: a guide for clinicians.
    Porcu M; Solinas C; Mannelli L; Micheletti G; Lambertini M; Willard-Gallo K; Neri E; Flanders AE; Saba L
    Crit Rev Oncol Hematol; 2020 Oct; 154():103068. PubMed ID: 32805498
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review.
    Roussel E; Capitanio U; Kutikov A; Oosterwijk E; Pedrosa I; Rowe SP; Gorin MA
    Eur Urol; 2022 May; 81(5):476-488. PubMed ID: 35216855
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.
    Kudura K; Ritz N; Kutzker T; Hoffmann MHK; Templeton AJ; Foerster R; Kreissl MC; Antwi K
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551581
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The artificial intelligence and machine learning in lung cancer immunotherapy.
    Gao Q; Yang L; Lu M; Jin R; Ye H; Ma T
    J Hematol Oncol; 2023 May; 16(1):55. PubMed ID: 37226190
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Artificial intelligence-based prediction of cervical lymph node metastasis in papillary thyroid cancer with CT.
    Wang C; Yu P; Zhang H; Han X; Song Z; Zheng G; Wang G; Zheng H; Mao N; Song X
    Eur Radiol; 2023 Oct; 33(10):6828-6840. PubMed ID: 37178202
    [TBL] [Abstract][Full Text] [Related]  

  • 91. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.
    Siebelink HM; Blanksma PK; Crijns HJ; Bax JJ; van Boven AJ; Kingma T; Piers DA; Pruim J; Jager PL; Vaalburg W; van der Wall EE
    J Am Coll Cardiol; 2001 Jan; 37(1):81-8. PubMed ID: 11153777
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
    Ligero M; Gielen B; Navarro V; Cresta Morgado P; Prior O; Dienstmann R; Nuciforo P; Trebeschi S; Beets-Tan R; Sala E; Garralda E; Perez-Lopez R
    NPJ Precis Oncol; 2024 Feb; 8(1):42. PubMed ID: 38383736
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers.
    Hope A; Verduin M; Dilling TJ; Choudhury A; Fijten R; Wee L; Aerts HJ; El Naqa I; Mitchell R; Vooijs M; Dekker A; de Ruysscher D; Traverso A
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069307
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Future Perspectives on Radiomics in Acute Liver Injury and Liver Trauma.
    Brunese MC; Avella P; Cappuccio M; Spiezia S; Pacella G; Bianco P; Greco S; Ricciardelli L; Lucarelli NM; Caiazzo C; Vallone G
    J Pers Med; 2024 May; 14(6):. PubMed ID: 38929793
    [No Abstract]   [Full Text] [Related]  

  • 95. Artificial intelligence in immunotherapy PET/SPECT imaging.
    McGale JP; Chen DL; Trebeschi S; Farwell MD; Wu AM; Cutler CS; Schwartz LH; Dercle L
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38355986
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy.
    McGale JP; Howell HJ; Beddok A; Tordjman M; Sun R; Chen D; Wu AM; Assi T; Ammari S; Dercle L
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399425
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.
    Dercle L; McGale J; Sun S; Marabelle A; Yeh R; Deutsch E; Mokrane FZ; Farwell M; Ammari S; Schoder H; Zhao B; Schwartz LH
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180071
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy.
    McGale J; Hama J; Yeh R; Vercellino L; Sun R; Lopci E; Ammari S; Dercle L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835808
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
    Alongi P; Rovera G; Stracuzzi F; Popescu CE; Minutoli F; Arnone G; Baldari S; Deandreis D; Caobelli F
    Curr Med Imaging; 2023; 19(8):832-843. PubMed ID: 36703586
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.